NeonMind Biosciences Inc.
NMDBF · OTC
11/30/2022 | 8/31/2022 | 5/31/2022 | 2/28/2022 | |
|---|---|---|---|---|
| Market Cap | $11 | $3,822 | $2,386 | $2,068 |
| - Cash | $36 | $17 | $2 | $137 |
| + Debt | $847 | $963 | $890 | $505 |
| Enterprise Value | $822 | $4,769 | $3,273 | $2,436 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$242 | $78 | -$769 | -$772 |
| % Margin | – | – | – | – |
| Net Income | -$179 | -$74 | -$900 | -$882 |
| % Margin | – | – | – | – |
| EPS Diluted | -4.75 | -0.063 | -0.84 | -0.83 |
| % Growth | -7,487.9% | 92.5% | -1.2% | – |
| Operating Cash Flow | $19 | -$58 | -$406 | -$636 |
| Capital Expenditures | $0 | $0 | $0 | $0 |
| Free Cash Flow | $19 | -$58 | -$406 | -$636 |